Stoke Therapeutics Receives FDA Breakthrough Therapy Designation for Zorevunersen for the ...
Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the ...
Medscape18 天
Non-alcoholic Fatty Liver Disease: Further Expression of the Metabolic Syndrome
On US, fatty infiltration of the liver produces a diffuse increase in echogenicity as compared with that of the kidneys. Regardless of the cause, cirrhosis has a similar appearance on US. US has a ...
Researchers identify a novel genetic cause of mitochondrial DNA depletion syndrome
Mitochondrial DNA depletion syndrome (MTDPS) is a rare genetic disorder characterized by a marked decrease in mitochondrial ...
Frontiers3 天
Therapeutic Targets and strategies in Long COVID and Post-Viral Syndromes
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a respiratory illness with systemic immune cell activation, inflammation, widespread multiorgan dysfunction, and thrombosis.